Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
A Phase III Randomized 1:1, Masked, Study of the Safety, Tolerability, and Efficacy of Intravitreal Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Adjuvant Management of TRD and Vit Hem Associated With PDR
Status: Enrolling
Updated:  1/14/2014
Retina Consultants of Houston
mi
from
Houston, TX
A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
A Phase III Randomized 1:1, Masked, Study of the Safety, Tolerability, and Efficacy of Intravitreal Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Adjuvant Management of TRD and Vit Hem Associated With PDR
Status: Enrolling
Updated: 1/14/2014
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
WaveLight® Refractive Flap Accuracy Study
A Prospective, Global, Multi-Center Study to Evaluate Longitudinal Flap Accuracy on Subjects Undergoing Myopic Refractive Surgery Using the WaveLight® Refractive Suite
Status: Enrolling
Updated:  1/14/2014
Alcon Call Center
mi
from
Fort Worth, TX
WaveLight® Refractive Flap Accuracy Study
A Prospective, Global, Multi-Center Study to Evaluate Longitudinal Flap Accuracy on Subjects Undergoing Myopic Refractive Surgery Using the WaveLight® Refractive Suite
Status: Enrolling
Updated: 1/14/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
WaveLight® Refractive Myopic Study
A Prospective, Global, Multi-Center Study for the Evaluation of Outcomes on Subjects Undergoing Myopic Treatments Using the WaveLight® Refractive Suite
Status: Enrolling
Updated:  1/15/2014
Alcon Call Center
mi
from
Fort Worth, TX
WaveLight® Refractive Myopic Study
A Prospective, Global, Multi-Center Study for the Evaluation of Outcomes on Subjects Undergoing Myopic Treatments Using the WaveLight® Refractive Suite
Status: Enrolling
Updated: 1/15/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Jonesboro, AR
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Boynton Beach, FL
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
West Palm Beach, FL
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
New Orleans, LA
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Detroit, MI
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Minneapolis, MN
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Philadelphia, PA
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated:  1/23/2014
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status: Enrolling
Updated: 1/23/2014
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
Status: Enrolling
Updated:  1/23/2014
Clinical Research Facility
mi
from
San Antonio, TX
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
Status: Enrolling
Updated: 1/23/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated:  1/28/2014
MIM-725 Investigational Site
mi
from
Waterbury, CT
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated: 1/28/2014
MIM-725 Investigational Site
mi
from
Waterbury, CT
Click here to add this to my saved trials
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated:  1/28/2014
MIM-725 Investigational Site
mi
from
Lewiston, ME
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated: 1/28/2014
MIM-725 Investigational Site
mi
from
Lewiston, ME
Click here to add this to my saved trials
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated:  1/28/2014
MIM-725 Investigational Site
mi
from
Andover, MA
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated: 1/28/2014
MIM-725 Investigational Site
mi
from
Andover, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated:  1/28/2014
MIM-725 Investigational Site
mi
from
Quincy, MA
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated: 1/28/2014
MIM-725 Investigational Site
mi
from
Quincy, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated:  1/28/2014
MIM-725 Investigational Site
mi
from
Memphis, TN
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye
Status: Enrolling
Updated: 1/28/2014
MIM-725 Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Clinical Evaluation of Systane Ultra Compared to Optive in Ocular Surface Staining
Clinical Evaluation of Systane Ultra Compared to Optive in Ocular Surface Staining
Status: Enrolling
Updated:  1/30/2014
Alcon Call Center
mi
from
Fort Worth, TX
Clinical Evaluation of Systane Ultra Compared to Optive in Ocular Surface Staining
Clinical Evaluation of Systane Ultra Compared to Optive in Ocular Surface Staining
Status: Enrolling
Updated: 1/30/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
OCT Agreement and Crossed Precision Study
Crossed Precision Design Study of the Nidek Optical Coherence Tomography RS-3000, RS-3000 Lite and RS-3000 Advance for the Measurements of Retinal and RNFL Thickness, Optic Disc Analysis, and Pachymetry
Status: Enrolling
Updated:  1/30/2014
WCCT Global Opthalmology Research Center
mi
from
Santa Ana, CA
OCT Agreement and Crossed Precision Study
Crossed Precision Design Study of the Nidek Optical Coherence Tomography RS-3000, RS-3000 Lite and RS-3000 Advance for the Measurements of Retinal and RNFL Thickness, Optic Disc Analysis, and Pachymetry
Status: Enrolling
Updated: 1/30/2014
WCCT Global Opthalmology Research Center
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
Beverly Hills, CA
Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
Colorado Springs, CO
Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
Boston, MA
Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
Houston, TX
Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2/3 Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis
A Single Center, Randomized, Double-Masked, Vehicle Controlled Phase 2/3 Study Evaluating the Efficacy and Safety of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model (CAC™)
Status: Enrolling
Updated:  2/12/2014
ORA Inc
mi
from
Andover, MA
Phase 2/3 Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis
A Single Center, Randomized, Double-Masked, Vehicle Controlled Phase 2/3 Study Evaluating the Efficacy and Safety of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model (CAC™)
Status: Enrolling
Updated: 2/12/2014
ORA Inc
mi
from
Andover, MA
Click here to add this to my saved trials
Ampyra for Optic Neuritis in MS
Dalfampridine After Optic Neuritis to Improve Visual Function in Multiple Sclerosis
Status: Enrolling
Updated:  2/14/2014
Washington University (John L. Trotter MS Center)
mi
from
St. Louis, MO
Ampyra for Optic Neuritis in MS
Dalfampridine After Optic Neuritis to Improve Visual Function in Multiple Sclerosis
Status: Enrolling
Updated: 2/14/2014
Washington University (John L. Trotter MS Center)
mi
from
St. Louis, MO
Click here to add this to my saved trials
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
A Phase I Dose Escalation Safety Study of Subretinally Injected RetinoStat, a Lentiviral Vector Expressing Endostatin and Angiostatin, in Patients With Advanced Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  2/22/2014
University of Iowa
mi
from
Iowa City, IA
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
A Phase I Dose Escalation Safety Study of Subretinally Injected RetinoStat, a Lentiviral Vector Expressing Endostatin and Angiostatin, in Patients With Advanced Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 2/22/2014
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
A Phase I Dose Escalation Safety Study of Subretinally Injected RetinoStat, a Lentiviral Vector Expressing Endostatin and Angiostatin, in Patients With Advanced Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  2/22/2014
Johns Hopkins University Hospital
mi
from
Baltimore, MD
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
A Phase I Dose Escalation Safety Study of Subretinally Injected RetinoStat, a Lentiviral Vector Expressing Endostatin and Angiostatin, in Patients With Advanced Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 2/22/2014
Johns Hopkins University Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
A Phase I Dose Escalation Safety Study of Subretinally Injected RetinoStat, a Lentiviral Vector Expressing Endostatin and Angiostatin, in Patients With Advanced Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  2/22/2014
Dr Andreas Lauer
mi
from
Portland, OR
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
A Phase I Dose Escalation Safety Study of Subretinally Injected RetinoStat, a Lentiviral Vector Expressing Endostatin and Angiostatin, in Patients With Advanced Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 2/22/2014
Dr Andreas Lauer
mi
from
Portland, OR
Click here to add this to my saved trials
DAILIES Total1® Lubricity Post Wear
Evaluation of the Lubricity of DAILIES Total1® Contact Lenses After Wear
Status: Enrolling
Updated:  2/25/2014
Alcon Call Center
mi
from
Fort Worth, TX
DAILIES Total1® Lubricity Post Wear
Evaluation of the Lubricity of DAILIES Total1® Contact Lenses After Wear
Status: Enrolling
Updated: 2/25/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Comparison of Postoperative Visual Acuity and Spectacle Independence Between the Tecnis Multifocal Intraoculer Lens (IOL) and the Crystalens Accommodating IOL
Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle Independence With Bilateral Implantation of the Tecnis Multifocal (TMF) Intraocular Lens or Crystalens AO (CAO) Intraocular Lens
Status: Enrolling
Updated:  2/26/2014
Drs. Fine, Hoffman and Packer, LLC
mi
from
Eugene, OR
Comparison of Postoperative Visual Acuity and Spectacle Independence Between the Tecnis Multifocal Intraoculer Lens (IOL) and the Crystalens Accommodating IOL
Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle Independence With Bilateral Implantation of the Tecnis Multifocal (TMF) Intraocular Lens or Crystalens AO (CAO) Intraocular Lens
Status: Enrolling
Updated: 2/26/2014
Drs. Fine, Hoffman and Packer, LLC
mi
from
Eugene, OR
Click here to add this to my saved trials
Selection of Aspheric Diffractive Multifocal Intraocular Lens (IOLS) Based on Corneal Wavefront
Selection of Aspheric Diffractive Multifocal IOLS Based on Corneal Wavefront
Status: Enrolling
Updated:  2/26/2014
Drs. Fine, Hoffman and Packer, LLC
mi
from
Eugene, OR
Selection of Aspheric Diffractive Multifocal Intraocular Lens (IOLS) Based on Corneal Wavefront
Selection of Aspheric Diffractive Multifocal IOLS Based on Corneal Wavefront
Status: Enrolling
Updated: 2/26/2014
Drs. Fine, Hoffman and Packer, LLC
mi
from
Eugene, OR
Click here to add this to my saved trials
First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration
A Randomized, Double-Masked, Vehicle-Controlled, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics of Single and Multiple Ascending Doses of Topically Delivered LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration
Status: Enrolling
Updated:  3/3/2014
Alcon Call Center
mi
from
Fort Worth, TX
First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration
A Randomized, Double-Masked, Vehicle-Controlled, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics of Single and Multiple Ascending Doses of Topically Delivered LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration
Status: Enrolling
Updated: 3/3/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy of PG101 for Dry Eye Syndrome
A Single Center, Randomized, Double-Masked, Placebo Controlled Study Evaluating the Safety and Efficacy of 0.25% PG101 and 1.0% PG101 in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  3/3/2014
Andover Eye
mi
from
Andover, MA
Safety and Efficacy of PG101 for Dry Eye Syndrome
A Single Center, Randomized, Double-Masked, Placebo Controlled Study Evaluating the Safety and Efficacy of 0.25% PG101 and 1.0% PG101 in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 3/3/2014
Andover Eye
mi
from
Andover, MA
Click here to add this to my saved trials
Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma
Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma
Status: Enrolling
Updated:  3/4/2014
UNC Kittner Eye Center
mi
from
Chapel Hill, NC
Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma
Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma
Status: Enrolling
Updated: 3/4/2014
UNC Kittner Eye Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated:  3/13/2014
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated: 3/13/2014
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Click here to add this to my saved trials
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated:  3/13/2014
VA Maryland Health Care System, Baltimore
mi
from
Baltimore, MD
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated: 3/13/2014
VA Maryland Health Care System, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated:  3/13/2014
Salisbury VAMC
mi
from
Salisbury, NC
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated: 3/13/2014
Salisbury VAMC
mi
from
Salisbury, NC
Click here to add this to my saved trials
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated:  3/13/2014
VA Medical Center, Cincinnati
mi
from
Cincinnati, OH
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated: 3/13/2014
VA Medical Center, Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated:  3/13/2014
VA Medical Center, Dayton
mi
from
Dayton, OH
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated: 3/13/2014
VA Medical Center, Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated:  3/13/2014
VA Medical Center, Philadelphia
mi
from
Philadelphia, PA
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated: 3/13/2014
VA Medical Center, Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated:  3/13/2014
William S. Middleton Memorial Veterans Hospital, Madison
mi
from
Madison, WI
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated: 3/13/2014
William S. Middleton Memorial Veterans Hospital, Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated:  3/13/2014
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Low Vision Intervention Trial II (LOVIT II)
VA Low Vision Intervention Trial (LOVIT) II
Status: Enrolling
Updated: 3/13/2014
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Status: Enrolling
Updated:  3/13/2014
Vitreo-Retinal Associates, PC
mi
from
Worcester, MA
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Status: Enrolling
Updated: 3/13/2014
Vitreo-Retinal Associates, PC
mi
from
Worcester, MA
Click here to add this to my saved trials
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Status: Enrolling
Updated:  3/19/2014
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Status: Enrolling
Updated: 3/19/2014
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration
A Multi-Center, Open-Label, Single Ascending Dose Study To Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal CLG561 in Subjects With Advanced Age-Related Macular Degeneration
Status: Enrolling
Updated:  3/24/2014
Alcon Call Center
mi
from
Fort Worth, TX
Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration
A Multi-Center, Open-Label, Single Ascending Dose Study To Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal CLG561 in Subjects With Advanced Age-Related Macular Degeneration
Status: Enrolling
Updated: 3/24/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Comparative Study of Two Daily Disposable Contact Lenses in Higher Myopia Subjects
Status: Enrolling
Updated:  3/24/2014
Alcon Call Center
mi
from
Fort Worth, TX
A Comparative Study of Two Daily Disposable Contact Lenses in Higher Myopia Subjects
Status: Enrolling
Updated: 3/24/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Changes in Tear Osmolarity Over Time With Sustained Use of TheraTears
Evaluation of Tear Osmolarity Over Time With Sustained Use of TheraTears Lubricating Drops
Status: Enrolling
Updated:  3/27/2014
Jenkins Eye Care
mi
from
Honolulu, HI
Changes in Tear Osmolarity Over Time With Sustained Use of TheraTears
Evaluation of Tear Osmolarity Over Time With Sustained Use of TheraTears Lubricating Drops
Status: Enrolling
Updated: 3/27/2014
Jenkins Eye Care
mi
from
Honolulu, HI
Click here to add this to my saved trials
PEMF: an Adjunct Therapy for Anterior Uveitis
PEMF an Adjunct Therapy for Anterior Uveitis
Status: Enrolling
Updated:  4/4/2014
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
PEMF: an Adjunct Therapy for Anterior Uveitis
PEMF an Adjunct Therapy for Anterior Uveitis
Status: Enrolling
Updated: 4/4/2014
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
Using in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Steroid Treatment in Dry Eye Disease
The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease
Status: Enrolling
Updated:  4/7/2014
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Using in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Steroid Treatment in Dry Eye Disease
The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease
Status: Enrolling
Updated: 4/7/2014
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials